がんチューブリン阻害剤のグローバル市場調査 2019年

• 英文タイトル：Global Cancer Tubulin Inhibitors Market Professional Survey Report 2019

• レポートコード：QYR9NV02115
• 出版社/出版日：QYResearch / 2019年11月12日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、がんチューブリン阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ドセタキセル、トラスツズマブエムタンシン、アブラキサン、ブレンツキシマブベドチン、カバジタキセルに、用途別には、非小細胞肺がん、前立腺がん、乳がん、大腸がん、卵巣がんにセグメント区分し、がんチューブリン阻害剤の世界市場を分析しました。

・エグゼクティブ・サマリー
・がんチューブリン阻害剤の世界市場概要
・がんチューブリン阻害剤の製造コスト構成分析
・がんチューブリン阻害剤の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・がんチューブリン阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・がんチューブリン阻害剤のセグメント分析（種類別）
（ドセタキセル、トラスツズマブエムタンシン、アブラキサン、ブレンツキシマブベドチン、カバジタキセル）
・がんチューブリン阻害剤のセグメント分析（用途別）
（非小細胞肺がん、前立腺がん、乳がん、大腸がん、卵巣がん）
・がんチューブリン阻害剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Abraxis Biosciences、Agensys、Amgen、Celgene、Eagle Pharmaceuticals、Endocyte、Genentech、Immunogen、Modra Pharmaceuticals、Pierre Fabre、Roche、Sanofi-Aventis、Seattle Genetics、Tocris Bioscience、）
・がんチューブリン阻害剤の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Cancer Tubulin Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cancer Tubulin Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Tubulin Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Tubulin Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer Tubulin Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abraxis Biosciences
Agensys
Amgen
Celgene
Eagle Pharmaceuticals
Endocyte
Genentech
Immunogen
Modra Pharmaceuticals
Pierre Fabre
Roche
Sanofi-Aventis
Seattle Genetics
Tocris Bioscience

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Docetaxel
Trastuzumab Emtansine
Abraxane
Brentuximab Vedotin
Cabazitaxel

Segment by Application
Non Small Cell Lung Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer
Ovarian Cancer

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Cancer Tubulin Inhibitors
1.1 Definition of Cancer Tubulin Inhibitors
1.2 Cancer Tubulin Inhibitors Segment by Type
1.2.1 Global Cancer Tubulin Inhibitors Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Docetaxel
1.2.3 Trastuzumab Emtansine
1.2.4 Abraxane
1.2.5 Brentuximab Vedotin
1.2.6 Cabazitaxel
1.3 Cancer Tubulin Inhibitors Segment by Applications
1.3.1 Global Cancer Tubulin Inhibitors Consumption Comparison by Applications (2014-2025)
1.3.2 Non Small Cell Lung Cancer
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Colorectal Cancer
1.3.6 Ovarian Cancer
1.4 Global Cancer Tubulin Inhibitors Overall Market
1.4.1 Global Cancer Tubulin Inhibitors Revenue (2014-2025)
1.4.2 Global Cancer Tubulin Inhibitors Production (2014-2025)
1.4.3 North America Cancer Tubulin Inhibitors Status and Prospect (2014-2025)
1.4.4 Europe Cancer Tubulin Inhibitors Status and Prospect (2014-2025)
1.4.5 China Cancer Tubulin Inhibitors Status and Prospect (2014-2025)
1.4.6 Japan Cancer Tubulin Inhibitors Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cancer Tubulin Inhibitors Status and Prospect (2014-2025)
1.4.8 India Cancer Tubulin Inhibitors Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer Tubulin Inhibitors
2.3 Manufacturing Process Analysis of Cancer Tubulin Inhibitors
2.4 Industry Chain Structure of Cancer Tubulin Inhibitors

3 Development and Manufacturing Plants Analysis of Cancer Tubulin Inhibitors
3.1 Capacity and Commercial Production Date
3.2 Global Cancer Tubulin Inhibitors Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cancer Tubulin Inhibitors
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Cancer Tubulin Inhibitors Production and Capacity Analysis
4.2 Cancer Tubulin Inhibitors Revenue Analysis
4.3 Cancer Tubulin Inhibitors Price Analysis
4.4 Market Concentration Degree

5 Cancer Tubulin Inhibitors Regional Market Analysis
5.1 Cancer Tubulin Inhibitors Production by Regions
5.1.1 Global Cancer Tubulin Inhibitors Production by Regions
5.1.2 Global Cancer Tubulin Inhibitors Revenue by Regions
5.2 Cancer Tubulin Inhibitors Consumption by Regions
5.3 North America Cancer Tubulin Inhibitors Market Analysis
5.3.1 North America Cancer Tubulin Inhibitors Production
5.3.2 North America Cancer Tubulin Inhibitors Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cancer Tubulin Inhibitors Import and Export
5.4 Europe Cancer Tubulin Inhibitors Market Analysis
5.4.1 Europe Cancer Tubulin Inhibitors Production
5.4.2 Europe Cancer Tubulin Inhibitors Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cancer Tubulin Inhibitors Import and Export
5.5 China Cancer Tubulin Inhibitors Market Analysis
5.5.1 China Cancer Tubulin Inhibitors Production
5.5.2 China Cancer Tubulin Inhibitors Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cancer Tubulin Inhibitors Import and Export
5.6 Japan Cancer Tubulin Inhibitors Market Analysis
5.6.1 Japan Cancer Tubulin Inhibitors Production
5.6.2 Japan Cancer Tubulin Inhibitors Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cancer Tubulin Inhibitors Import and Export
5.7 Southeast Asia Cancer Tubulin Inhibitors Market Analysis
5.7.1 Southeast Asia Cancer Tubulin Inhibitors Production
5.7.2 Southeast Asia Cancer Tubulin Inhibitors Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Cancer Tubulin Inhibitors Import and Export
5.8 India Cancer Tubulin Inhibitors Market Analysis
5.8.1 India Cancer Tubulin Inhibitors Production
5.8.2 India Cancer Tubulin Inhibitors Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Cancer Tubulin Inhibitors Import and Export

6 Cancer Tubulin Inhibitors Segment Market Analysis (by Type)
6.1 Global Cancer Tubulin Inhibitors Production by Type
6.2 Global Cancer Tubulin Inhibitors Revenue by Type
6.3 Cancer Tubulin Inhibitors Price by Type

7 Cancer Tubulin Inhibitors Segment Market Analysis (by Application)
7.1 Global Cancer Tubulin Inhibitors Consumption by Application
7.2 Global Cancer Tubulin Inhibitors Consumption Market Share by Application (2014-2019)

8 Cancer Tubulin Inhibitors Major Manufacturers Analysis
8.1 Abraxis Biosciences
8.1.1 Abraxis Biosciences Cancer Tubulin Inhibitors Production Sites and Area Served
8.1.2 Abraxis Biosciences Product Introduction, Application and Specification
8.1.3 Abraxis Biosciences Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Agensys
8.2.1 Agensys Cancer Tubulin Inhibitors Production Sites and Area Served
8.2.2 Agensys Product Introduction, Application and Specification
8.2.3 Agensys Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Amgen
8.3.1 Amgen Cancer Tubulin Inhibitors Production Sites and Area Served
8.3.2 Amgen Product Introduction, Application and Specification
8.3.3 Amgen Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celgene
8.4.1 Celgene Cancer Tubulin Inhibitors Production Sites and Area Served
8.4.2 Celgene Product Introduction, Application and Specification
8.4.3 Celgene Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eagle Pharmaceuticals
8.5.1 Eagle Pharmaceuticals Cancer Tubulin Inhibitors Production Sites and Area Served
8.5.2 Eagle Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Eagle Pharmaceuticals Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Endocyte
8.6.1 Endocyte Cancer Tubulin Inhibitors Production Sites and Area Served
8.6.2 Endocyte Product Introduction, Application and Specification
8.6.3 Endocyte Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Genentech
8.7.1 Genentech Cancer Tubulin Inhibitors Production Sites and Area Served
8.7.2 Genentech Product Introduction, Application and Specification
8.7.3 Genentech Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Immunogen
8.8.1 Immunogen Cancer Tubulin Inhibitors Production Sites and Area Served
8.8.2 Immunogen Product Introduction, Application and Specification
8.8.3 Immunogen Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Modra Pharmaceuticals
8.9.1 Modra Pharmaceuticals Cancer Tubulin Inhibitors Production Sites and Area Served
8.9.2 Modra Pharmaceuticals Product Introduction, Application and Specification
8.9.3 Modra Pharmaceuticals Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Pierre Fabre
8.10.1 Pierre Fabre Cancer Tubulin Inhibitors Production Sites and Area Served
8.10.2 Pierre Fabre Product Introduction, Application and Specification
8.10.3 Pierre Fabre Cancer Tubulin Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Roche
8.12 Sanofi-Aventis
8.13 Seattle Genetics
8.14 Tocris Bioscience

9 Development Trend of Analysis of Cancer Tubulin Inhibitors Market
9.1 Global Cancer Tubulin Inhibitors Market Trend Analysis
9.1.1 Global Cancer Tubulin Inhibitors Market Size (Volume and Value) Forecast 2019-2025
9.2 Cancer Tubulin Inhibitors Regional Market Trend
9.2.1 North America Cancer Tubulin Inhibitors Forecast 2019-2025
9.2.2 Europe Cancer Tubulin Inhibitors Forecast 2019-2025
9.2.3 China Cancer Tubulin Inhibitors Forecast 2019-2025
9.2.4 Japan Cancer Tubulin Inhibitors Forecast 2019-2025
9.2.5 Southeast Asia Cancer Tubulin Inhibitors Forecast 2019-2025
9.2.6 India Cancer Tubulin Inhibitors Forecast 2019-2025
9.3 Cancer Tubulin Inhibitors Market Trend (Product Type)
9.4 Cancer Tubulin Inhibitors Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Cancer Tubulin Inhibitors Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Cancer Tubulin Inhibitors
Table Global Cancer Tubulin Inhibitors Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Cancer Tubulin Inhibitors Production Market Share by Types in 2018
Figure Docetaxel Product Picture
Figure Trastuzumab Emtansine Product Picture
Figure Abraxane Product Picture
Figure Brentuximab Vedotin Product Picture
Figure Cabazitaxel Product Picture
Table Global Cancer Tubulin Inhibitors Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Cancer Tubulin Inhibitors Consumption Market Share by Applications in 2018
Figure Non Small Cell Lung Cancer
Figure Prostate Cancer
Figure Breast Cancer
Figure Colorectal Cancer
Figure Ovarian Cancer
Figure Global Cancer Tubulin Inhibitors Revenue (Million USD) (2014-2025)
Figure Global Cancer Tubulin Inhibitors Production (K Pcs) (2014-2025)
Figure North America Cancer Tubulin Inhibitors Market Size (Million USD) (2014-2025)
Figure Europe Cancer Tubulin Inhibitors Market Size (Million USD) (2014-2025)
Figure China Cancer Tubulin Inhibitors Market Size (Million USD) (2014-2025)
Figure Japan Cancer Tubulin Inhibitors Market Size (Million USD) (2014-2025)
Figure Southeast Asia Cancer Tubulin Inhibitors Market Size (Million USD) (2014-2025)
Figure India Cancer Tubulin Inhibitors Market Size (Million USD) (2014-2025)
Table Cancer Tubulin Inhibitors Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cancer Tubulin Inhibitors in 2018
Figure Manufacturing Process Analysis of Cancer Tubulin Inhibitors
Figure Industry Chain Structure of Cancer Tubulin Inhibitors
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Cancer Tubulin Inhibitors Manufacturing Plants Distribution
Table Cancer Tubulin Inhibitors Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Cancer Tubulin Inhibitors Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer Tubulin Inhibitors Production (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer Tubulin Inhibitors Production Market Share of Major Manufacturers (2014-2019)
Figure Cancer Tubulin Inhibitors Production Share by Manufacturers in 2018
Table Cancer Tubulin Inhibitors Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Cancer Tubulin Inhibitors Revenue Market Share of Major Manufacturers (2014-2019)
Figure Cancer Tubulin Inhibitors Revenue Share by Manufacturers in 2018
Table Cancer Tubulin Inhibitors Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Cancer Tubulin Inhibitors Production by Regions 2014-2019 (K Pcs)
Table Global Cancer Tubulin Inhibitors Production Market Share by Regions 2014-2019
Figure Global Cancer Tubulin Inhibitors Production Market Share by Regions in 2018
Table Global Cancer Tubulin Inhibitors Revenue by Regions 2014-2019 (Million USD)
Table Global Cancer Tubulin Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Cancer Tubulin Inhibitors Revenue Market Share by Regions in 2018
Table Global Cancer Tubulin Inhibitors Consumption by Regions 2014-2019 (K Pcs)
Table Global Cancer Tubulin Inhibitors Consumption Market Share by Regions 2014-2019
Figure North America Cancer Tubulin Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure North America Cancer Tubulin Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table North America Cancer Tubulin Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Europe Cancer Tubulin Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Cancer Tubulin Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Cancer Tubulin Inhibitors Production, Consumption Import and Export (K Pcs)
Figure China Cancer Tubulin Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure China Cancer Tubulin Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table China Cancer Tubulin Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Japan Cancer Tubulin Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Cancer Tubulin Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Cancer Tubulin Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Cancer Tubulin Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Cancer Tubulin Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Cancer Tubulin Inhibitors Production, Consumption Import and Export (K Pcs)
Figure India Cancer Tubulin Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure India Cancer Tubulin Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table India Cancer Tubulin Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Cancer Tubulin Inhibitors Market Share by Application (2014-2019)
Figure Global Value (Consumption) Cancer Tubulin Inhibitors Market Share by Application (2014-2019)
Table Abraxis Biosciences Cancer Tubulin Inhibitors Production Sites and Area Served
Table Abraxis Biosciences Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Abraxis Biosciences Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abraxis Biosciences Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Abraxis Biosciences Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Abraxis Biosciences Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Abraxis Biosciences Cancer Tubulin Inhibitors Main Business and Markets Served
Table Agensys Cancer Tubulin Inhibitors Production Sites and Area Served
Table Agensys Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Agensys Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Agensys Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Agensys Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Agensys Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Agensys Cancer Tubulin Inhibitors Main Business and Markets Served
Table Amgen Cancer Tubulin Inhibitors Production Sites and Area Served
Table Amgen Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Amgen Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Amgen Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Amgen Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Amgen Cancer Tubulin Inhibitors Main Business and Markets Served
Table Celgene Cancer Tubulin Inhibitors Production Sites and Area Served
Table Celgene Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Celgene Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Celgene Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Celgene Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Celgene Cancer Tubulin Inhibitors Main Business and Markets Served
Table Eagle Pharmaceuticals Cancer Tubulin Inhibitors Production Sites and Area Served
Table Eagle Pharmaceuticals Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Eagle Pharmaceuticals Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eagle Pharmaceuticals Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Eagle Pharmaceuticals Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Eagle Pharmaceuticals Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Eagle Pharmaceuticals Cancer Tubulin Inhibitors Main Business and Markets Served
Table Endocyte Cancer Tubulin Inhibitors Production Sites and Area Served
Table Endocyte Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Endocyte Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Endocyte Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Endocyte Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Endocyte Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Endocyte Cancer Tubulin Inhibitors Main Business and Markets Served
Table Genentech Cancer Tubulin Inhibitors Production Sites and Area Served
Table Genentech Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Genentech Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genentech Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Genentech Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Genentech Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Genentech Cancer Tubulin Inhibitors Main Business and Markets Served
Table Immunogen Cancer Tubulin Inhibitors Production Sites and Area Served
Table Immunogen Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Immunogen Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immunogen Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Immunogen Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Immunogen Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Immunogen Cancer Tubulin Inhibitors Main Business and Markets Served
Table Modra Pharmaceuticals Cancer Tubulin Inhibitors Production Sites and Area Served
Table Modra Pharmaceuticals Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Modra Pharmaceuticals Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Modra Pharmaceuticals Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Modra Pharmaceuticals Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Modra Pharmaceuticals Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Modra Pharmaceuticals Cancer Tubulin Inhibitors Main Business and Markets Served
Table Pierre Fabre Cancer Tubulin Inhibitors Production Sites and Area Served
Table Pierre Fabre Cancer Tubulin Inhibitors Product Introduction, Application and Specification
Table Pierre Fabre Cancer Tubulin Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pierre Fabre Cancer Tubulin Inhibitors Production Growth Rate (2014-2019)
Table Pierre Fabre Cancer Tubulin Inhibitors Production Market Share (2014-2019)
Figure Pierre Fabre Cancer Tubulin Inhibitors Revenue Market Share (2014-2019)
Table Pierre Fabre Cancer Tubulin Inhibitors Main Business and Markets Served
Table Roche Cancer Tubulin Inhibitors Production Sites and Area Served
Table Sanofi-Aventis Cancer Tubulin Inhibitors Production Sites and Area Served
Table Seattle Genetics Cancer Tubulin Inhibitors Production Sites and Area Served
Table Tocris Bioscience Cancer Tubulin Inhibitors Production Sites and Area Served
Figure Global Cancer Tubulin Inhibitors Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Cancer Tubulin Inhibitors Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Cancer Tubulin Inhibitors Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Cancer Tubulin Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Cancer Tubulin Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Cancer Tubulin Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Cancer Tubulin Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Cancer Tubulin Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Cancer Tubulin Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Cancer Tubulin Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Cancer Tubulin Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Cancer Tubulin Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Cancer Tubulin Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Cancer Tubulin Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Cancer Tubulin Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Cancer Tubulin Inhibitors by Type (2019-2025)
Table Global Consumption (K Pcs) of Cancer Tubulin Inhibitors by Application (2019-2025)
Table Cancer Tubulin Inhibitors Distributors List
Table Cancer Tubulin Inhibitors Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

がんCDK阻害剤のグローバル市場調査 2019年

Global Cancer CDK Inhibitors Market Professional Survey Report 2019
QYR9NV02109 2019年11月12日 111Pages
※本調査レポートは、がんCDK阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、前臨床、フェーズI、フェーズI / II、フェーズII、フェーズIIIに、...

がんmTOR阻害剤のグローバル市場調査 2019年

Global Cancer mTOR Inhibitors Market Professional Survey Report 2019
QYR9NV02112 2019年11月12日 114Pages
※本調査レポートは、がんmTOR阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アフィニトール/ Votubia、Afinitor Disperz an...

PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場：規模・現状・予測2019-2025

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV18254 2019年11月18日 92Pages
※当調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場について調査・分析し、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...

PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場：規模・現状・予測2019-2025

非チロシンキナーゼ阻害剤のグローバル市場調査 2019年

Global Non-Tyrosine Kinase Inhibitors Market Professional Survey Report 2019
QYR9NV09033 2019年11月14日 112Pages
※本調査レポートは、非チロシンキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、mTOR阻害剤、RAF / MEK阻害剤、CDK阻害剤に、用途別に...

世界のMEK阻害剤産業調査2019-2025

Global MEK Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16443 2019年11月16日 118Pages
※本調査レポートでは、世界のMEK阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。MEK阻害剤の種類別には、メキニスト、コテリック、メクトビに、用途別には、NSCLC、がんに、地域別には、北米、アメリカ、ヨ...

世界のMEK阻害剤産業調査2019-2025

ヒストン脱アセチル化酵素阻害剤のグローバル市場調査 2019年

Global Histone Deacetylase Inhibitors Market Professional Survey Report 2019
QYR9NV06218 2019年11月12日 115Pages
※本調査レポートは、ヒストン脱アセチル化酵素阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、競合阻害剤、非競合阻害剤、混合阻害剤に、用途別には、精神神経...

ヒストン脱アセチル化酵素（HDAC）阻害剤のグローバル市場調査 2019年

Global Histone Deacetylase(HDAC) Inhibitors Market Professional Survey Report 2019
QYR9NV06219 2019年11月12日 113Pages
※本調査レポートは、ヒストン脱アセチル化酵素（HDAC）阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヒドロキサム酸、環状テトラペプチド、ベンズアミド...

BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV17679 2019年11月18日 93Pages
※当調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場について調査・分析し、BCL-2（B細胞リンパ腫2）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用...

がんCDK阻害剤のグローバル市場調査 2019年 The global Cancer CDK Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer CDK Inhibitors volume and value at global level, regional level and company level. From a global perspective, …
がんmTOR阻害剤のグローバル市場調査 2019年 The global Cancer mTOR Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer mTOR Inhibitors volume and value at global level, regional level and company level. From a global perspective…
PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場：規模・現状・予測2019-2025 PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoti…
PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場：規模・現状・予測2019-2025 PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoti…
非チロシンキナーゼ阻害剤のグローバル市場調査 2019年 The global Non-Tyrosine Kinase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non-Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a gl…